Public Notice on Environmental Impact Assessment of Yantai Shun Kang Biotechnology Co., Ltd.'s Pharmaceutical Intermediates Series Production Project
Release time:
2025-05-19
In accordance with the relevant provisions of the "Environmental Impact Assessment Law of the People's Republic of China" and the "Measures for Public Participation in Environmental Impact Assessment" (Ministry of Ecology and Environment Order No. 4), the environmental impact report for the pharmaceutical intermediate product production project of Yantai ShunKang Biotechnology Co., Ltd. is hereby announced before submission for approval.
I. Basic Information of the Construction Project
Project Name: Pharmaceutical Intermediate Product Production Project of Yantai ShunKang Biotechnology Co., Ltd.
Construction Location: Emei Road East, Provincial Chemical Industry Park, Laiyang Economic and Technological Development Zone
Construction Nature: Expansion
Construction Content: This project has a total investment of 131.73 million yuan and a newly built area of 17,341 square meters. The project includes three pharmaceutical intermediate production lines, a wastewater treatment plant, and supporting facilities such as warehouses. Specifically: (1) Production Scale: Annual production of 500 tons of 1,2,3,4-Tetrahydropyrazino[1,2-a]indole, 25 tons of 1-methyl-3-propylpyrazole-5-carboxylic acid, and 100 tons of 4-acetamido-3-methoxy-fluorobenzene; (2) Wastewater Treatment Plant Capacity: 300 tons/day.
II. Public Announcement Content
Environmental Impact Report for Approval and Public Participation Statement
Contact the construction unit to view the paper report.
III. Name and Contact Information of the Construction Unit
Construction Unit: Yantai ShunKang Biotechnology Co., Ltd.
Contact Person: Manager Gao
Contact Address: No. 2, Emei Road, Laiyang Economic and Technological Development Zone, Shandong Province
Contact Number: 0535-7876609
Related News
Related accessories
